NO751117L - - Google Patents

Info

Publication number
NO751117L
NO751117L NO751117A NO751117A NO751117L NO 751117 L NO751117 L NO 751117L NO 751117 A NO751117 A NO 751117A NO 751117 A NO751117 A NO 751117A NO 751117 L NO751117 L NO 751117L
Authority
NO
Norway
Prior art keywords
interferon
solution
agent
surfactant
urea
Prior art date
Application number
NO751117A
Other languages
English (en)
Norwegian (no)
Inventor
W E Stewart
P M H F De Somer
Original Assignee
Stichting Rega V Z W
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting Rega V Z W filed Critical Stichting Rega V Z W
Publication of NO751117L publication Critical patent/NO751117L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1133—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by redox-reactions involving cystein/cystin side chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO751117A 1974-04-03 1975-04-02 NO751117L (cs)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7404590A NL7404590A (nl) 1974-04-03 1974-04-03 Werkwijze voor het reactiveren van interferon.

Publications (1)

Publication Number Publication Date
NO751117L true NO751117L (cs) 1975-10-06

Family

ID=19821110

Family Applications (1)

Application Number Title Priority Date Filing Date
NO751117A NO751117L (cs) 1974-04-03 1975-04-02

Country Status (12)

Country Link
US (1) US4017600A (cs)
JP (1) JPS5191319A (cs)
AU (1) AU7951075A (cs)
BE (1) BE826890A (cs)
DE (1) DE2514536A1 (cs)
DK (1) DK139875A (cs)
FI (1) FI750952A7 (cs)
FR (1) FR2266741B3 (cs)
IT (1) IT1045540B (cs)
NL (1) NL7404590A (cs)
NO (1) NO751117L (cs)
SE (1) SE7503770L (cs)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5562024A (en) * 1978-10-31 1980-05-10 Hayashibara Takeshi Preventive and remedy for interferon-sensitive disease
IN150740B (cs) * 1978-11-24 1982-12-04 Hoffmann La Roche
US4503035B1 (en) * 1978-11-24 1996-03-19 Hoffmann La Roche Protein purification process and product
US6410697B1 (en) 1979-04-20 2002-06-25 Schering Corporation Process for purifying human leukocyte interferon
US4289689A (en) * 1980-03-14 1981-09-15 Hoffmann-La Roche Inc. Preparation of homogeneous human fibroblast interferon
DE3278234D1 (en) * 1981-10-13 1988-04-21 Exovir Inc Interferon-containing compositions and the use of these compositions in the treatment of herpetic infections, pre-malignant skin lesions, skin malignancies and psoriasis
US5582824A (en) * 1981-10-19 1996-12-10 Genentech, Inc. Recombinant DES-CYS-TYR-CYS human immune interferon
US4432895A (en) * 1982-11-24 1984-02-21 Hoffmann-La Roche Inc. Monomeric interferons
US4511503A (en) * 1982-12-22 1985-04-16 Genentech, Inc. Purification and activity assurance of precipitated heterologous proteins
US4681930A (en) * 1983-09-20 1987-07-21 Hoffmann-La Roche Inc. Immune interferon and a method for its extraction and purification
US4476049A (en) * 1983-09-20 1984-10-09 Hoffmann-La Roche Inc. Method for the extraction of immune interferon
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor
MX9203641A (es) * 1983-12-16 1992-07-01 Genentech Inc Interferones gamma recombinantes que poseen estabilidad mejorada y metodos biotecnologicos para su obtencion.
IL74093A0 (en) * 1984-01-23 1985-04-30 Takeda Chemical Industries Ltd Stable composition of gamma-interferon
US4499014A (en) * 1984-02-07 1985-02-12 Interferon Sciences, Inc. Method for purifying gamma-interferon
DE3421302A1 (de) * 1984-06-08 1985-12-12 Hoechst Ag, 6230 Frankfurt Verfahren zur isolierung und reinigung von (alpha)-interferonen
EP0195084B1 (de) * 1984-09-21 1990-05-23 Vsesojuzny Nauchno-Issledovatelsky Institut Osobo Chistykh Biopreparatov Rektifizierungsverfahren menschlichen leukozyten-interferons
US4950470A (en) * 1986-10-06 1990-08-21 Board Of Regents, The University Of Texas System Methods and compositions employing interferon-gamma
US4999422A (en) * 1988-04-15 1991-03-12 Biogen, N.V. Continuous method of refolding proteins
US5165921A (en) * 1989-01-23 1992-11-24 National Geno Sciences, Inc. Method for treating condyloma acuminatum with interferon
US5236707A (en) * 1991-11-08 1993-08-17 Dallas Biotherapeutics, Inc. Stabilization of human interferon

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (cs) * 1962-01-03

Also Published As

Publication number Publication date
FR2266741A1 (cs) 1975-10-31
SE7503770L (sv) 1975-10-06
NL7404590A (nl) 1975-10-07
AU7951075A (en) 1976-09-30
FI750952A7 (cs) 1975-10-04
BE826890A (nl) 1975-09-22
DK139875A (cs) 1975-10-04
JPS5191319A (en) 1976-08-10
US4017600A (en) 1977-04-12
DE2514536A1 (de) 1975-10-09
FR2266741B3 (cs) 1977-12-16
IT1045540B (it) 1980-05-10

Similar Documents

Publication Publication Date Title
NO751117L (cs)
NO751118L (cs)
US4396608A (en) Intravenously injectable immune serum globulin
KR100186824B1 (ko) 알부민 제제 및 이의 제조방법
DK156698B (da) Fremgangsmaade til pasteurisering af et materiale indeholdende et termisk foelsomt, terapeutisk aktivtprotein valgt blandt alfa-l-antitrypsin, antithrombin-iii, praekallikrein, antihaemofil faktor (faktorviii) og fibronectin
Castellino et al. The denaturing effectiveness of guanidinium, carbamoylguanidinium, and guanylguanidinium salts
RU2112522C1 (ru) Состав для стабилизации плазмы крови, способ пастеризации плазмы и использование стабилизированной плазмы в терапии
NO328450B1 (no) Stabilt farmasøytisk preparat inneholdende faktor VIII
JPS6237010B2 (cs)
Teresi The combination of organic anions with serum albumin. VII. The protein sites involved in the combination
JPS6219406B2 (cs)
JP2879427B2 (ja) ウイルスおよびバクテリア汚染物の熱的不活性化中の生物学的および製薬的生成物の安定化
JPS6089428A (ja) 血漿蛋白の加熱処理方法
KR950010321B1 (ko) 인간 트롬빈 제제의 가열처리방법
US9023797B2 (en) Caprylate viral deactivation
US5116950A (en) Process for heat treating fibrinogen
JPH03130232A (ja) 安定化白血球インタフェロン
Cesario et al. Relationship between the physicochemical nature of human interferon, the cell induced, and the inducing agent
JP2001000179A (ja) ウィルスの不活化方法
JPS6122022A (ja) 血漿蛋白の加熱処理方法
EP0179075B2 (en) Virus risk-reduced hemoglobin and method for making same
WO1999051279A1 (en) A method for treating contaminated products and articles
JPH0278633A (ja) ウイルス不活化方法
JPH04352727A (ja) 耐熱性の改善された血清アルブミン組成物
KR100276155B1 (ko) 화학적으로 변형되지 않은 γ-글로불린 제제